As of Monday, LianBio’s (NASDAQ:LIAN) stock closed at $2.00, down from $2.02 the previous day. While LianBio has underperformed by -0.99%, investors are advised to look at stock chart patterns for technical insight.
Top 5 EV Tech Stocks to Buy for 2023
The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".
Click Here to Download the FREE Report.
Sponsored
Analysis of LianBio (LIAN)
One of the most important indicators of LianBio’s future performance is equity, which can be evaluated using several well-rounded types of analysis and research techniques. The goal here is to ensure that your current return on equity of -40.00% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 11.40, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
For any stock, average volume can also provide valuable insight into volatility, and LIAN is recording 195.28K average volume. On a monthly basis, the volatility of the stock is set at 7.13%, whereas on a weekly basis, it is put at 10.33%, with a loss of -8.26% over the past seven days. Furthermore, long-term investors anticipate a median target price of $7.78, showing growth from the present price of $2.00, which can serve as yet another indication of whether LIAN is worth investing in or should be passed over.
How Do You Analyze LianBio Shares?
Along with the fundamentals, it is also important to consider how many employees own shares of the company. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 5.92%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 78.10% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
At the end of the first quarter, T. Rowe Price Associates, Inc. decreased its LIAN holdings by -5.37% and now holds 2.54 million LIAN shares valued at $5.79 million with the lessened -0.14 million shares during the period. LIAN shares are owned by institutional investors to the tune of 78.10% at present.
